… criteria: COPD diagnosis, decline in lung function/FEV 1 , and … components, one fluticasone
propionate/salmeterol and the … acetylcysteine, and one used ipratropium bromide. All studies …

… of treatment with inhaled fluticasone, but no statistically … rapidly improved lung function,
health status, morning symptoms … with significant improvements in lung function, predose FEV …

… as partially preventable causes of accelerated lung aging in … This study showed a trend
towards improved survival in … ® ), including anticholinergics (ipratropium bromide or tiotropium …

… symptoms, but empirical evidence supporting such practice is sparse. We evaluated the effect
of LAMA and LABA on lung function improvement … salbutamol and ipratropium inhalation …

… improving lung function and symptoms in patients with moderate to very severe COPD.
Further research is warranted as additional evidence regarding triple therapies, especially fixed-…

… in this disease can improve lung function as measured by … single inhaler containing both
ipratropium and albuterol can … may be responsible for the improved symptom control with FF/VI. …

… Thus, the impact on lung function of a combination with fluticasone propionate and … In
particular, both FSC and ipratropium bromide/salbutamol improved lung function, symptoms, and …

… -dose ICS/LABA (fluticasone propionate/salmeterol [FP/SLM]) … lung function were assessed
using Functional Respiratory … /FF compared to those receiving ipratropium. However, that …

… Ipratropium bromide is the major SAMA used in the US and … Unlike atropine, ipratropium
bromide in the airway is poorly … has been shown to improve lung function, symptoms and quality-…

… (albuterol, levalbuterol, or ipratropium bromide) within 3 months prior to … lung function
improvement is faster for fluticasone furoate/vilanterol than fluticasone propionate/salmeterol both …